FDA product code DGC: Ige, Antigen, Antiserum, Control
DGC is the FDA product code for ige, antigen, antiserum, control. It is a Class II device, regulated under 21 CFR 866.5510 and reviewed by the Immunology panel. FDA has cleared 114 510(k) submissions under DGC, 3 in the last five years, from 56 different applicants. The average 510(k) review took 65 days (median 45); 403 days on average over the last three years. FDA has posted 3 recalls for DGC devices.
Classification
| Field | Value |
|---|---|
| Device name | Ige, Antigen, Antiserum, Control |
| Device class | Class II |
| Regulation | 21 CFR 866.5510 |
| Review panel | IM — Immunology |
| Medical specialty | Immunology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for DGC
| Year | Clearances | Avg. review days |
|---|---|---|
| 2020 | 1 | 29 |
| 2022 | 1 | 61 |
| 2023 | 1 | 421 |
| 2024 | 1 | 403 |
Compare with all 510(k) review times · Search every DGC clearance
Top DGC applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Pharmacia, Inc. | 16 | 1997-04-23 |
| Ventrex Laboratories, Inc. | 12 | 1991-02-21 |
| Kallestad Laboratories, Inc. | 8 | 1985-07-10 |
| Diagnostic Products Corp. | 6 | 1989-09-28 |
| Hybritech, Inc. | 4 | 1986-11-03 |
51 more applicants have DGC clearances. See the full list in Caduvo.
Most recent DGC clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K231151 | Kenota, Inc. | Kenota 1 Total IgE; Kenota 1 (instrument) | 2024-05-31 | 403 |
| K214068 | Biokit, S.A. | Quantia IgE | 2023-02-21 | 421 |
| K220178 | Beckman Coulter, Inc. | Total Immunoglobulin E (IgE) | 2022-03-23 | 61 |
| K193493 | Siemens Healthcare Diagnostics, Inc. | ADVIA Centaur Total IgE (tIgE) | 2020-01-15 | 29 |
| K161899 | Phadia AB | ImmunoCAP Total IgE Calibrator Strip/Total IgE Curve Control Strip, ImmunoCAP Total IgE Calibrators/Total IgE Curve Controls, ImmunoCAP Specific IgE Calibrator Strip/Specific IgE Curve Control Strip, ImmunoCAP Specific IgE Calibrators/Specific IgE Curve Controls | 2016-07-28 | 17 |
Recalls for DGC devices
3 product recalls in 3 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2018-03-05.
| Year | Recalls |
|---|---|
| 2018 | 1 |
Frequently asked questions
What is FDA product code DGC?
DGC is the FDA product code for ige, antigen, antiserum, control. It is a Class II device, regulated under 21 CFR 866.5510 and reviewed by the Immunology panel.
What device class is DGC?
Class II, regulation 21 CFR 866.5510. Typical premarket route: 510(k).
How long does a 510(k) take for product code DGC?
Across 114 cleared submissions the average was 65 days from receipt to decision (median 45).
Which companies have the most DGC clearances?
Pharmacia, Inc. (16); Ventrex Laboratories, Inc. (12); Kallestad Laboratories, Inc. (8); Diagnostic Products Corp. (6); Hybritech, Inc. (4).
Have DGC devices been recalled?
Yes: 3 product recalls across 3 recall events; the most recent began 2018-03-05.
Next steps
- Run an FDA pathway report with predicate devices for product code DGC
- Run a recall and safety report across every DGC manufacturer
- Watch product code DGC for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times